Supporting the designation of July 19, 2023, as "Glioblastoma Awareness Day".

HRES 425 is a non-binding House resolution designating July 19, 2023, as "Glioblastoma Awareness Day" to increase public recognition of glioblastoma, an aggressive brain cancer. It directly supports patients, caregivers, and families affected by the disease, which has a low 5-year survival rate (6.9%) and no effective screening methods. The resolution encourages greater public awareness, honors those impacted by the disease, and urges continued research investments, including through the Glioblastoma Therapeutics Network. It does not create new laws or alter funding but serves as a symbolic statement to advance understanding and support for glioblastoma research.